http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Morihiro Kogure,Naomi Mimura,Hideshi Ikemoto,Shintaro Ishikawa,Takako Nakanishi-Ueda,Masataka Sunagawa,Tadashi Hisamitsu 사단법인약침학회 2012 Journal of Acupuncture & Meridian Studies Vol.5 No.1
The purpose of this study was to compare the effectiveness of moxibustion (MOX) treatment at the GV4 and CV12 acupoints, and to determine the correlations between MOX treatment and interleukin (IL)-6 and corticosterone levels in a collagen-induced arthritis (CIA) mouse model. CIA mice were immunized twice intradermally over a 3-week interval with bovine type II collagen. After the second immunization (day 21), MOX was applied to the mouse equivalent of the GV4 and CV12 acupoints with a 1 mg moxa cone five times/day. Clinical symptoms of CIA were observed three times/week until day 35. The concentrations of IL-6 and corticosterone in the blood samples were measured by immunoassay kits. At day 35, the incidence of CIA was significantly decreased in mice treated with MOX at the GV4 acupoint (78%, nZ23, p < 0.05), compared to untreated CIA mice (100%) and mice treated with MOX at the CV12 acupoint (100%). IL-6 and corticosterone levels were significantly increased by immunization. IL-6 levels significantly decreased in mice treated with MOX at the GV4 acupoint. These results suggest that MOX treatment suppressed CIA at the GV4 acupoint, not at the CV12 acupoint, possibly through inhibition of IL-6 production.
Nobuyoshi Kosaka,Akiko Kogure,Tomofumi Yamamoto,Fumihiko Urabe,Wataru Usuba,Marta Prieto-Vila,Takahiro Ochiya 생화학분자생물학회 2019 Experimental and molecular medicine Vol.51 No.-
Liquid biopsy is indispensable for the resolution of current medical issues, such as the cost of developing new drugs and predicting responses of patients to drugs. In this sense, not only the technology for liquid biopsy but also the target biomolecules for biomarkers need to be identified. Extracellular vesicles (EVs), which contain various proteins, including membrane-bound proteins, and RNAs, including mRNA and long/short noncoding RNAs, have emerged as ideal targets for liquid biopsy. These complex biomolecules are covered by a lipid bilayer, which can protect them from degradation. In this review, we review current topics regarding EVs as cancer biomarkers and introduce technologies used for these recently emerged biomolecules.
Usefulness of stent placement above the papilla, so-called, ‘inside stent’
Tanyaporn Chantarojanasiri,Hirofumi Kogure,Tsuyoshi Hamada,Hiroyuki Isayama 소화기인터벤션의학회 2018 Gastrointestinal Intervention Vol.7 No.2
Stent occlusion and cholangitis are common complications after endoscopic biliary stenting caused by duodenobiliary refluxes and food impaction. To prolong the stent patency, the concept of stenting above the papilla, so-called inside stent, has been developed. Various studies of the inside stent in the treatment of both benign and malignant biliary obstruction have been published, with a promising result. However, most studies were retrospective, with wide variation of stent type and the etiology of biliary obstruction. This review aims to summarize the principle, evidence, and the usefulness of inside biliary stent.
Endoscopic Ultrasound-Guided Biliary Drainage for Unresectable Hilar Malignant Biliary Obstruction
Yousuke Nakai,Hirofumi Kogure,Hiroyuki Isayama,Kazuhiko Koike 대한소화기내시경학회 2019 Clinical Endoscopy Vol.52 No.3
Endoscopic transpapillary biliary drainage is the current standard of care for unresectable hilar malignant biliary obstruction (MBO)and bilateral metal stent placement is shown to have longer patency. However, technical and clinical failure is possible and percutaneoustranshepatic biliary drainage (PTBD) is sometimes necessary. Endoscopic ultrasound-guided biliary drainage (EUS-BD) is increasinglybeing reported as an alternative rescue procedure to PTBD. EUS-BD has a potential advantage of not traversing the biliary strictureand internal drainage can be completed in a single session. Some approaches to bilateral biliary drainage for hilar MBO under EUSguidanceinclude a bridging method, hepaticoduodenostomy, and a combination of EUS-BD and transpapillary biliary drainage. Theaim of this review is to summarize data on EUS-BD for hilar MBO and to clarify its advantages over the conventional approaches suchas endoscopic transpapillary biliary drainage and PTBD.